Adelaide Medical School
Faculty of Health and Medical Sciences
Aneta joined the Intellectual Disability Research Group at the end of 2016. The focus of the group is to gain a deeper understanding of the gene mutations that cause intellectual disability, autism, and seizures in children. Aneta is specifically investigating the effect estradiol has on seizures and understanding the molecular changes the treatment may have on the brain.
Prior to this, Aneta undertook her PhD in the Breast Cancer Research Unit. Her project investigated the anti-cancer efficacy of a small population of immune cells, in combination with a drug used for osteoporosis against cancers in the bone.
Date Position Institution name 2016 Research Associate University of Adelaide, Adelaide
Awards and Achievements
Date Type Title Institution Name Amount 2017 Award Northern Communities Foundation Prize University of Adelaide 2016 Award Wellcome Trust Travel Grant King's College London 2015 Award Best Senior PhD Oral Presentation (Laboratory) 2015 Achievement Finalist for the Ross Wishart Award (ASMR) 2014 Award Best Lay Description Prize 2014 Award School of Medicine Poster Presentation Prize University of Adelaide 2014 Award SAHMRI Beat Cancer Project Travel Grant 2014 2013 Scholarship Australian Postgraduate Award 2012 Scholarship Royal Adelaide Hospital Research Committee Scholarship 2011 Award Faculty of Sciences Outstanding Academic Achievement Award University of Adelaide 2010 Scholarship Cancer Council SA Student Vacation Scholarship University of Adelaide
Language Competency English Can read, write, speak, understand spoken and peer review Polish Can speak and understand spoken
Date Institution name Country Title 2013 - 2017 University of Adelaide, Adelaide Australia Doctor of Philosophy 2012 - 2012 University of Adelaide, Adelaide Australia Bachelor of Science (Honours - Biochemistry) 2009 - 2011 University of Adelaide, Adelaide Australia Bachelor of Science (Molecular Biology)
Year Citation 2017 Zysk, A., DeNichilo, M., Panagopoulos, V., Zinonos, I., Liapis, V., Hay, S. ... Evdokiou, A. (2017). Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer. Cancer Letters, 386, 141-150.
2017 Wang, Y., Zinonos, I., Zysk, A., Panagopoulos, V., Kaur, G., Santos, A. ... Evdokiou, A. (2017). In vivo toxicological assessment of electrochemically engineered anodic alumina nanotubes: a study of biodistribution, subcutaneous implantation and intravenous injection. Journal of Materials Chemistry B, 5, 13, 2511-2523.
2017 Liapis, V., Zysk, A., DeNichilo, M., Zinonos, I., Hay, S., Panagopoulos, V. ... Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma. Cancer Medicine, 6, 9, 2164-2176.
2016 Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V. ... Evdokiou, A. (2016). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. Cancer Medicine, 5, 3, 534-545.
2016 DeNichilo, M., Shoubridge, A., Panagopoulos, V., Liapis, V., Zysk, A., Zinonos, I. ... Evdokiou, A. (2016). Peroxidase enzymes regulate collagen biosynthesis and matrix mineralization by cultured human osteoblasts. Calcified Tissue International, 98, 3, 294-305.
2015 Wang, Y., Kaur, G., Zysk, A., Liapis, V., Hay, S., Santos, A. ... Evdokiou, A. (2015). Systematic invitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: understanding nanotoxicity by a nanomaterial model. Biomaterials, 46, 117-130.
2015 Panagopoulos, V., Zinonos, I., Leach, D., Hay, S., Liapis, V., Zysk, A. ... Evdokiou, A. (2015). Uncovering a new role for peroxidase enzymes as drivers of angiogenesis. The International Journal of Biochemistry and Cell Biology, 68, 128-138.
Connect With Me